Skip to content

Effect of synbiotics supplement on fatigue and sleep quality in hemodialysis patients with chronic kidney disease

Effect of synbiotics supplement on fatigue and sleep quality in hemodialysis patients with chronic kidney disease

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210117050055N1
Enrollment
60
Registered
2021-02-21
Start date
2021-04-04
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease. Chronic kidney disease, stage 4 (severe)

Interventions

Intervention 1: Intervention group: Intervention: Recipient of Lactococare synbiotic dietary supplement capsule (500 mg) containing 12 beneficial bacterial(Lactobacillus rhamnosus, Lactobacillus holot

Sponsors

Sabzevar University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: A patient with a diagnosis of chronic kidney disease who undergoing hemodialysis for at least 3 months. signing informed consent for participation in the study Patient with arteriovenous fistula or permanent catheter or venous arterial graft The patient undergoing hemodialysis 3 times a week for 4 hours each time Patient with KT / V> 1 Do not suffer from hearing and vision disorders No neurological disorders and a history of hospitalization in the psychiatric ward age range of 18 to 65 years

Exclusion criteria

Exclusion criteria: Active infection during the last 30 days Pregnant or lactating mothers Taking antibiotics, prebiotics, probiotics, synbiotics, vitamin supplements or antioxidants during the last 30 days Suffering from autoimmune diseases or connective tissue disorders History of cardiovascular diseases Diabetic foot infection Gastrointestinal diseases (inflammatory bowel disease, ulcerative colitis, Crohn's disease, celiac disease, lactose intolerance or allergy, irritable bowel syndrome) Liver disease (such as hepatitis B, hepatitis C) suffering from various types of malignancies Smoking more than 10 cigarettes per day Participate in other drug interventions hemoglobin less than 8 mg/dl PSQI score less than 6 (good sleep quality) acquisition of CFS score less than 18

Design outcomes

Primary

MeasureTime frame
Fatigue. Timepoint: 2 months. Method of measurement: Chalders Fatigue Scale.;Sleep quality. Timepoint: 2 months. Method of measurement: Pittsburgh Sleep Quality Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMina Jangpoor

Sabzevar University of Medical Sciences

mina.jangpoor@gmail.com+98 51 4401 8300

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026